Status: Baseline only
Most Recent Data:
12.4
percent
(2016)
Target:
15.9
percent
Desired Direction:
Increase desired
Baseline:
12.4 percent of Medicare beneficiaries aged 18 to 75 years with sickle cell anemia received disease modifying therapies in accordance with the National Heart, Lung, and Blood Institute (NHLBI)'s guidelines in 2016
View CI in the chart by hovering over a data point.
View SE in the chart by hovering over a data point.
Confidence Interval (CI) not available Standard Error (SE) not available Confidence Interval (CI) and Standard Error (SE) are not available
Medicare beneficiaries with sickle cell anemia receiving disease modifying therapies, 2016 ◊
(percent)
Increase desired
Population | 2016 |
---|---|
Total |
12.4
|